Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3491 185 0
Emcee:  dalroi Type:  Moderated
this forum is for firesale alerts

stock need to drop more then 15% in 1 day
1/ dont spam on this board
2/ if in the next days it doesnt drop 15% discuss it somewhere else

reversals are ok as long as the post is made around the 15% droppoint

try to give a reason why it did it and use the ticker in headline

mean reason for this board IS ALLERTING so one knows there is something going on
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3491Halozyme's (HALO) PEGPH20 combo with mFFOX did far worse on OS than mFFOX altuck-Tuesday
3490How about Multikine?rkrw-January 9
3489Axsome (AXSM) pain trial halted for futility, sending shares down 30%. A similatuck-January 9
3488OHRP—Did any fake-drug candidate live longer? Possibly Bavituximab. My post-mortDewDiligence_on_SI-January 8
3487Editas (EDIT) off 17% and other Crispr stocks (CRSP, NTLA) also weak after this tuck-January 8
3486Axovant's stock tumbles toward record low after disappointing drug trial resJulius Wong-January 8
3485<statistically significantly worse> I wouldn't be surprised.Miljenko Zuanic-January 5
3484Amazing and finally put them to sleep. I wish they had disclosed the p-value. Srkrw-January 5
3483 "Squlamine is finally DEAD, for real. After + 25 years. Did any fake-drug Bladerunner17-January 5
3482RE: OHRP, Ohr Pharmaceutical Announces Efficacy Results from Miljenko Zuanic2January 5
3481See Syros commentary . Scroll down a little ways and note Ozgur's commentstuck-12/12/2017
3480Strong rebound today ... i sold a few otm calls that got in the money for severasemi_infinite -12/12/2017
3479VistaGen (VTGN) off 35% on financing after a huge spike on a patent issuance. Ktuck-12/11/2017
3478AFMD off 17% this morning. I'm not sure why. Were the results presented atBladerunner17-12/11/2017
3477Syros (SYRS), a recent IPO, failed utterly at ASH this weekend, and is off 46% atuck-12/11/2017
3476I was looking at it yesterday and again today. There is hardly any call premiumsemi_infinite -12/6/2017
3475Neuralstem (CUR) off nearly 30%. Yesterday, it almost tripled on a well spun trituck-12/6/2017
3474Galectin (GALT) off 44% pre-market on NASH cirrhosis P2 fail (that is being spuntuck-12/5/2017
3473DBVT -50% AH because there was not enough differentiation from placebo A poll atnsaf-10/22/2017
3472FWIW, seeing twitter chatter regarding management's caginess regarding the ntuck-10/12/2017
3471ACRX down 60% on CRL. Is there value here? I thought Dsuvia would be approved.Bladerunner17-10/12/2017
3470Momenta (MNTA) off 16% as Mylan gets approval for both doses of generic Copaxonetuck-10/4/2017
3469Yeah, sector a bit split last couple of days Companies with best science and buscaram(o)uche-9/29/2017
3468Interesting as bio indexes churn a bit that THE JIMS stocks just exploding higheRobohogs-9/29/2017
3467See?? I'm so distracted that I didn't realize that Friedman was a part scaram(o)uche-9/28/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.